Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 330

1.

Development and validation of the Axillary Sweating Daily Diary: a patient-reported outcome measure to assess axillary sweating severity.

Nelson LM, DiBenedetti D, Pariser DM, Glaser DA, Hebert AA, Hofland H, Drew J, Ingolia D, Gillard KK, Fehnel S.

J Patient Rep Outcomes. 2019 Sep 5;3(1):59. doi: 10.1186/s41687-019-0148-8.

2.

Development, psychometric evaluation, and initial feasibility assessment of a symptom tracker for use by patients with heart failure (HFaST).

Lewis EF, Coles TM, Lewis S, Nelson LM, Barrett A, Romano CD, Stull DE, Turner SJ, Chang CG.

J Patient Rep Outcomes. 2019 May 2;3(1):26. doi: 10.1186/s41687-019-0113-6.

3.

Influence of Crohn's disease related polymorphisms in innate immune function on ileal microbiome.

Li E, Zhang Y, Tian X, Wang X, Gathungu G, Wolber A, Shiekh SS, Sartor RB, Davidson NO, Ciorba MA, Zhu W, Nelson LM, Robertson CE, Frank DN.

PLoS One. 2019 Feb 28;14(2):e0213108. doi: 10.1371/journal.pone.0213108. eCollection 2019.

4.

Validation of an algorithm for identifying MS cases in administrative health claims datasets.

Culpepper WJ, Marrie RA, Langer-Gould A, Wallin MT, Campbell JD, Nelson LM, Kaye WE, Wagner L, Tremlett H, Chen LH, Leung S, Evans C, Yao S, LaRocca NG; United States Multiple Sclerosis Prevalence Workgroup (MSPWG).

Neurology. 2019 Mar 5;92(10):e1016-e1028. doi: 10.1212/WNL.0000000000007043. Epub 2019 Feb 15.

5.

The prevalence of MS in the United States: A population-based estimate using health claims data.

Wallin MT, Culpepper WJ, Campbell JD, Nelson LM, Langer-Gould A, Marrie RA, Cutter GR, Kaye WE, Wagner L, Tremlett H, Buka SL, Dilokthornsakul P, Topol B, Chen LH, LaRocca NG; US Multiple Sclerosis Prevalence Workgroup.

Neurology. 2019 Mar 5;92(10):e1029-e1040. doi: 10.1212/WNL.0000000000007035. Epub 2019 Feb 15. Erratum in: Neurology. 2019 Oct 8;93(15):688.

6.

A new way to estimate neurologic disease prevalence in the United States: Illustrated with MS.

Nelson LM, Wallin MT, Marrie RA, Culpepper WJ, Langer-Gould A, Campbell J, Buka S, Tremlett H, Cutter G, Kaye W, Wagner L, Larocca NG; United States Multiple Sclerosis Prevalence Workgroup.

Neurology. 2019 Mar 5;92(10):469-480. doi: 10.1212/WNL.0000000000007044. Epub 2019 Feb 15. Review.

7.

Evaluation of a Mobile Device Survey System for Behavioral Risk Factors (SHAPE): App Development and Usability Study.

Oakley-Girvan I, Lavista JM, Miller Y, Davis S, Acle C, Hancock J, Nelson LM.

JMIR Form Res. 2019 Jan 11;3(1):e10246. doi: 10.2196/10246.

8.

Physical Activity and Parkinson Disease Risk: An Intriguing Link.

Nelson LM.

JAMA Netw Open. 2018 Sep 7;1(5):e182633. doi: 10.1001/jamanetworkopen.2018.2633. No abstract available.

PMID:
30646161
9.

Fragile X Associated Primary Ovarian Insufficiency (FXPOI): Case Report and Literature Review.

Fink DA, Nelson LM, Pyeritz R, Johnson J, Sherman SL, Cohen Y, Elizur SE.

Front Genet. 2018 Nov 27;9:529. doi: 10.3389/fgene.2018.00529. eCollection 2018. Review.

10.

Quantification of Agrobacterium vitis from Grapevine Nursery Stock and Vineyard Soil using Droplet Digital PCR.

Voegel TM, Nelson LM.

Plant Dis. 2018 Nov;102(11):2136-2141. doi: 10.1094/PDIS-02-18-0342-RE. Epub 2018 Sep 10.

PMID:
30198827
11.

Estimation of the Prevalence of Amyotrophic Lateral Sclerosis in the United States Using National Administrative Healthcare Data from 2002 to 2004 and Capture-Recapture Methodology.

Nelson LM, Topol B, Kaye W, Williamson D, Horton DK, Mehta P, Wagner T.

Neuroepidemiology. 2018;51(3-4):149-157. doi: 10.1159/000488798. Epub 2018 Aug 9.

12.

Pseudomonads contribute to regulation of Pratylenchus penetrans (Nematoda) populations on apple.

Watson TT, Forge TA, Nelson LM.

Can J Microbiol. 2018 Nov;64(11):775-785. doi: 10.1139/cjm-2018-0040. Epub 2018 May 23.

PMID:
29791808
13.

Efficacy of Pseudomonas fluorescens for control of Mucor rot of apple during commercial storage and potential modes of action.

Wallace RL, Hirkala DL, Nelson LM.

Can J Microbiol. 2018 Jun;64(6):420-431. doi: 10.1139/cjm-2017-0776. Epub 2018 Mar 5.

PMID:
29505734
14.

A randomized controlled study of a consent intervention for participating in an NIH genome sequencing study.

Turbitt E, Chrysostomou PP, Peay HL, Heidlebaugh AR, Nelson LM, Biesecker BB.

Eur J Hum Genet. 2018 May;26(5):622-630. doi: 10.1038/s41431-018-0105-7. Epub 2018 Feb 16.

15.

Long-term health-related quality-of-life and symptom response profiles with arformoterol in COPD: results from a 52-week trial.

Donohue JF, Bollu VK, Stull DE, Nelson LM, Williams VS, Stensland MD, Hanania NA.

Int J Chron Obstruct Pulmon Dis. 2018 Feb 5;13:499-508. doi: 10.2147/COPD.S141729. eCollection 2018.

16.

Quantifying the importance of inhaler attributes corresponding to items in the patient satisfaction and preference questionnaire in patients using Combivent Respimat.

Davis KH, Su J, González JM, Trudeau JJ, Nelson LM, Hauber B, Hollis KA.

Health Qual Life Outcomes. 2017 Oct 16;15(1):201. doi: 10.1186/s12955-017-0780-z.

17.

Obstetric interventions and maternal morbidity among women who experience severe postpartum hemorrhage during cesarean delivery.

Seligman K, Ramachandran B, Hegde P, Riley ET, El-Sayed YY, Nelson LM, Butwick AJ.

Int J Obstet Anesth. 2017 May;31:27-36. doi: 10.1016/j.ijoa.2017.03.009. Epub 2017 Mar 22.

18.

Risk Factors for Severe Postpartum Hemorrhage After Cesarean Delivery: Case-Control Studies.

Butwick AJ, Ramachandran B, Hegde P, Riley ET, El-Sayed YY, Nelson LM.

Anesth Analg. 2017 Aug;125(2):523-532. doi: 10.1213/ANE.0000000000001962.

19.

Effect of Calcineurin Inhibitor-Free, Everolimus-Based Immunosuppressive Regimen on Albuminuria and Glomerular Filtration Rate After Heart Transplantation.

Nelson LM, Andreassen AK, Andersson B, Gude E, Eiskjær H, Rådegran G, Dellgren G, Gullestad L, Gustafsson F.

Transplantation. 2017 Nov;101(11):2793-2800. doi: 10.1097/TP.0000000000001706.

PMID:
28230646
20.

Health Status of Patients with Moderate to Severe COPD after Treatment with Nebulized Arformoterol Tartrate or Placebo for 1 Year.

Donohue JF, Ganapathy V, Bollu V, Stensland MD, Nelson LM.

Clin Ther. 2017 Jan;39(1):66-74. doi: 10.1016/j.clinthera.2016.11.021. Epub 2016 Dec 20.

PMID:
28011247
21.

Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause.

Sullivan SD, Sarrel PM, Nelson LM.

Fertil Steril. 2016 Dec;106(7):1588-1599. doi: 10.1016/j.fertnstert.2016.09.046. Review.

22.

Outcomes Associated With the Intrepid Dynamic Exoskeletal Orthosis (IDEO): A Systematic Review of the Literature.

Highsmith MJ, Nelson LM, Carbone NT, Klenow TD, Kahle JT, Hill OT, Maikos JT, Kartel MS, Randolph BJ.

Mil Med. 2016 Nov;181(S4):69-76. Review.

PMID:
27849465
23.

A Review of Unique Considerations for Female Veterans With Amputation.

Randolph BJ, Nelson LM, Highsmith MJ.

Mil Med. 2016 Nov;181(S4):66-68.

PMID:
27849464
24.

A design thinking approach to primary ovarian insufficiency.

Martin LA, Porter AG, Pelligrini VA, Schnatz PF, Jiang X, Kleinstreuer N, Hall JE, Verbiest S, Olmstead J, Fair R, Falorni A, Persani L, Rajkovic A, Mehta K, Nelson LM; Rachel's Well Primary Ovarian Insufficiency Community of Practice Group.

Panminerva Med. 2017 Mar;59(1):15-32. doi: 10.23736/S0031-0808.16.03259-6. Epub 2016 Nov 9.

PMID:
27827529
25.

Hormone replacement therapy in young women with surgical primary ovarian insufficiency.

Sarrel PM, Sullivan SD, Nelson LM.

Fertil Steril. 2016 Dec;106(7):1580-1587. doi: 10.1016/j.fertnstert.2016.09.018. Epub 2016 Oct 25. Review.

26.

Cytokinin production by Pseudomonas fluorescens G20-18 determines biocontrol activity against Pseudomonas syringae in Arabidopsis.

Großkinsky DK, Tafner R, Moreno MV, Stenglein SA, García de Salamone IE, Nelson LM, Novák O, Strnad M, van der Graaff E, Roitsch T.

Sci Rep. 2016 Mar 17;6:23310. doi: 10.1038/srep23310.

27.

Major depression in hospitalized Argentine general medical patients: Prevalence and risk factors.

Yanzón de la Torre A, Oliva N, Echevarrieta PL, Pérez BG, Caporusso GB, Titaro AJ, Todaro Kicyla A, Cuatz M, Locatelli M, Nelson LM, Mac Mullen M, Baldessarini RJ, Daray FM.

J Affect Disord. 2016 Jun;197:36-42. doi: 10.1016/j.jad.2016.02.066. Epub 2016 Mar 2.

PMID:
26967917
28.

Proteome-wide survey of the autoimmune target repertoire in autoimmune polyendocrine syndrome type 1.

Landegren N, Sharon D, Freyhult E, Hallgren Å, Eriksson D, Edqvist PH, Bensing S, Wahlberg J, Nelson LM, Gustafsson J, Husebye ES, Anderson MS, Snyder M, Kämpe O.

Sci Rep. 2016 Feb 1;6:20104. doi: 10.1038/srep20104.

29.

Racial and Ethnic Disparities in Mode of Anesthesia for Cesarean Delivery.

Butwick AJ, Blumenfeld YJ, Brookfield KF, Nelson LM, Weiniger CF.

Anesth Analg. 2016 Feb;122(2):472-9. doi: 10.1213/ANE.0000000000000679.

30.

Psychosocial Vulnerability, Resilience Resources, and Coping with Infertility: A Longitudinal Model of Adjustment to Primary Ovarian Insufficiency.

Driscoll MA, Davis MC, Aiken LS, Yeung EW, Sterling EW, Vanderhoof V, Calis KA, Popat V, Covington SN, Nelson LM.

Ann Behav Med. 2016 Apr;50(2):272-84. doi: 10.1007/s12160-015-9750-z.

PMID:
26637185
31.

Psychometric validation of the Psoriasis Symptom Diary using Phase III study data from patients with chronic plaque psoriasis.

Strober B, Zhao Y, Tran MH, Gnanasakthy A, Nyirady J, Papavassilis C, Nelson LM, McLeod LD, Mordin M, Gottlieb AB, Elewski BE, Lebwohl M.

Int J Dermatol. 2016 Mar;55(3):e147-55. doi: 10.1111/ijd.13117. Epub 2015 Oct 30.

PMID:
26518255
32.

Outcome in patients treated with isolated liver transplantation for familial transthyretin amyloidosis to prevent cardiomyopathy.

Nelson LM, Penninga L, Villadsen GE, Mølgaard H, Eiskjaer H, Hillingsø JG, Rasmussen A.

Clin Transplant. 2015 Dec;29(12):1098-104. doi: 10.1111/ctr.12633. Epub 2015 Oct 21.

PMID:
26361241
33.

The effects of continuing care on emerging adult outcomes following residential addiction treatment.

Bergman BG, Hoeppner BB, Nelson LM, Slaymaker V, Kelly JF.

Drug Alcohol Depend. 2015 Aug 1;153:207-14. doi: 10.1016/j.drugalcdep.2015.05.017. Epub 2015 May 27.

34.

Update on primary ovarian insufficiency in adolescents.

Gordon CM, Kanaoka T, Nelson LM.

Curr Opin Pediatr. 2015 Aug;27(4):511-9. doi: 10.1097/MOP.0000000000000236. Review.

PMID:
26087426
35.

Risk of Cardiovascular Disease Associated with a Restless Legs Syndrome Diagnosis in a Retrospective Cohort Study from Kaiser Permanente Northern California.

Van Den Eeden SK, Albers KB, Davidson JE, Kushida CA, Leimpeter AD, Nelson LM, Popat R, Tanner CM, Bibeau K, Quesenberry CP.

Sleep. 2015 Jul 1;38(7):1009-15. doi: 10.5665/sleep.4800.

36.

Comparison of adequate relief with symptom, global, and responder endpoints in linaclotide phase 3 trials in IBS-C.

Camilleri M, Lembo AJ, Lavins BJ, MacDougall JE, Carson RT, Williams VS, Nelson LM, Shiff SJ, Currie MG, Kurtz CB, Johnston JM.

United European Gastroenterol J. 2015 Feb;3(1):53-62. doi: 10.1177/2050640614555946.

37.

Factors associated with anti-human leukocyte antigen antibodies in patients supported with continuous-flow devices and effect on probability of transplant and post-transplant outcomes.

Alba AC, Tinckam K, Foroutan F, Nelson LM, Gustafsson F, Sander K, Bruunsgaard H, Chih S, Hayes H, Rao V, Delgado D, Ross HJ.

J Heart Lung Transplant. 2015 May;34(5):685-92. doi: 10.1016/j.healun.2014.11.024. Epub 2014 Dec 8.

PMID:
25638296
38.

Risk Factors for Prolonged Postpartum Length of Stay Following Cesarean Delivery.

Blumenfeld YJ, El-Sayed YY, Lyell DJ, Nelson LM, Butwick AJ.

Am J Perinatol. 2015 Jul;32(9):825-32. doi: 10.1055/s-0034-1543953. Epub 2015 Jan 16.

39.

Second-line uterotonics and the risk of hemorrhage-related morbidity.

Butwick AJ, Carvalho B, Blumenfeld YJ, El-Sayed YY, Nelson LM, Bateman BT.

Am J Obstet Gynecol. 2015 May;212(5):642.e1-7. doi: 10.1016/j.ajog.2015.01.008. Epub 2015 Jan 9.

40.

Characteristics and long-term outcome of patients with systemic immunoglobulin light-chain amyloidosis.

Nelson LM, Gustafsson F, Gimsing P.

Acta Haematol. 2015;133(4):336-46. doi: 10.1159/000363682. Epub 2014 Dec 16.

PMID:
25531398
41.

Current Sample Size Practices in the Psychometric Evaluation of Patient-Reported Outcomes for Use in Clinical Trials.

Coles TM, Chen WH, Nelson LM, Williams V, McLeod LD.

Value Health. 2014 Nov;17(7):A571. doi: 10.1016/j.jval.2014.08.1909. Epub 2014 Oct 26. No abstract available.

42.

Psychometric validation of patient-reported outcome measures assessing chronic constipation.

Nelson LM, Williams VS, Fehnel SE, Carson RT, MacDougall J, Baird MJ, Tourkodimitris S, Kurtz CB, Johnston JM.

Clin Exp Gastroenterol. 2014 Sep 26;7:385-94. doi: 10.2147/CEG.S64713. eCollection 2014.

43.

A clinical research integration special program (CRISP) for young women with primary ovarian insufficiency.

Falorni A, Minarelli V, Eads CM, Joachim CM, Persani L, Rossetti R, Yurttas Beim P, Pellegrini VA, Schnatz PF, Rafique S, Kissell K, Calis KA, Popat V, Nelson LM.

Panminerva Med. 2014;56(4):245-61. Epub 2014 Oct 7. Review.

44.

An open letter to the primary ovarian insufficiency community.

Joachim CM, Eads CM, Persani L, Yurttas Beim P, Nelson LM.

Minerva Ginecol. 2014 Oct;66(5):519-20. No abstract available.

45.

Psychometric validation of symptom severity measures in irritable bowel syndrome with constipation.

Williams VS, Nelson LM, Fehnel SE, MacDougall J, Carson RT, Tourkodimitris S, Kurtz C, Baird MJ, Johnston JM.

Aliment Pharmacol Ther. 2014 Aug;40(3):298-308. doi: 10.1111/apt.12830. Epub 2014 Jun 18.

46.

Bone mineral density in young women with primary ovarian insufficiency: results of a three-year randomized controlled trial of physiological transdermal estradiol and testosterone replacement.

Popat VB, Calis KA, Kalantaridou SN, Vanderhoof VH, Koziol D, Troendle JF, Reynolds JC, Nelson LM.

J Clin Endocrinol Metab. 2014 Sep;99(9):3418-26. doi: 10.1210/jc.2013-4145. Epub 2014 Jun 6.

47.

Treatment effectiveness of pasireotide on health-related quality of life in patients with Cushing's disease.

Webb SM, Ware JE, Forsythe A, Yang M, Badia X, Nelson LM, Signorovitch JE, McLeod L, Maldonado M, Zgliczynski W, de Block C, Portocarrero-Ortiz L, Gadelha M.

Eur J Endocrinol. 2014 Jul;171(1):89-98. doi: 10.1530/EJE-13-1013. Epub 2014 Apr 23.

PMID:
24760537
48.

Quantitative challenges facing patient-centered outcomes research.

Chen WH, McLeod LD, Nelson LM, Williams VS, Fehnel SE.

Expert Rev Pharmacoecon Outcomes Res. 2014 Jun;14(3):379-86. doi: 10.1586/14737167.2014.912133. Epub 2014 Apr 23. Review.

PMID:
24758551
49.

Effects of physiologic testosterone therapy on quality of life, self-esteem, and mood in women with primary ovarian insufficiency.

Guerrieri GM, Martinez PE, Klug SP, Haq NA, Vanderhoof VH, Koziol DE, Popat VB, Kalantaridou SN, Calis KA, Rubinow DR, Schmidt PJ, Nelson LM.

Menopause. 2014 Sep;21(9):952-61. doi: 10.1097/GME.0000000000000195.

50.

The Flat Earth Society: a rose by any other name?

Nelson LM.

Hum Reprod. 2014 Feb;29(2):190-2. doi: 10.1093/humrep/det443. Epub 2013 Dec 16. No abstract available.

Supplemental Content

Loading ...
Support Center